Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Hypertension
Hypertension is a major risk factor for cardiovascular disease. Remote ischemic conditioning (RIC) and mindfulness-based interventions are non-pharmacological approaches that may help reduce blood pressure through different physiological mechanisms. However, evidence regarding their long-term effects and potential combined benefits remains limited.
This multicenter, randomized, sham-controlled clinical trial evaluated the effects of RIC, mindfulness-based intervention, and their combination on home blood pressure in patients with hypertension. A total of 600 participants were randomly assigned to four groups in a 2×2 factorial design. The interventions were administered twice daily for 12 months. The primary objective was to assess changes in home systolic blood pressure after 12 months of intervention. Secondary objectives included evaluating diastolic blood pressure, the time course of blood pressure changes, treatment response, and safety.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
This was a multicenter, randomized, sham-controlled, 2×2 factorial clinical trial conducted at five hospitals in China. A total of 600 patients with essential hypertension were enrolled between September 2023 and August 2024 and randomly assigned in a 1:1:1:1 ratio to four intervention groups:
- Control group: sham remote ischemic conditioning (RIC) combined with nature-sound audio.
- RIC group: active RIC combined with nature-sound audio.
- Mindfulness group: sham RIC combined with guided mindfulness intervention.
- Combination group: active RIC combined with guided mindfulness intervention.
Active RIC consisted of three cycles of upper-arm cuff inflation for 6 minutes followed by deflation for 4 minutes, with a total session duration of 30 minutes. Inflation pressure was individualized according to baseline systolic blood pressure using predefined pressure increments. Sham RIC followed the same inflation-deflation schedule with a cuff pressure of 60 mmHg.
The mindfulness intervention consisted of standardized audio-guided mindfulness practice delivered simultaneously with the cuff intervention. The control audio consisted of natural sounds, such as ocean waves, flowing water, and birdsong, without hypertension education or mindfulness instructions. Both interventions were administered twice daily for 12 months.
Home blood pressure was measured repeatedly throughout the study using an automated monitoring system. The primary outcome was the change in pre-intervention home systolic blood pressure from baseline to 12 months. Additional assessments included diastolic blood pressure, longitudinal blood pressure trajectories, blood pressure control and response rates, immediate blood pressure responses, treatment adherence, and adverse events.
Selected circulating biomarkers were also measured in a subset of participants for mechanistic investigations.
The study was designed to assess the independent and combined effects of RIC and mindfulness-based intervention on long-term blood pressure control.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Luoyang、中国、471000
- The First Affiliated Hospital of Henan University of Science and Technology
-
-
Henan
-
Anyang、Henan、中国、455000
- Anyang District Hospital
-
Kaifeng、Henan、中国、475000
- Huaihe Hospital of Henan University
-
Shangqiu、Henan、中国、476600
- Yongcheng Central Hospital
-
Zhengzhou、Henan、中国、450008
- Fuwai central China Cardiovascular hospital
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adults aged 18-80 years.
- Diagnosis of essential hypertension according to established clinical guidelines, with a mean screening home systolic blood pressure (SBP) of 135-179 mmHg and a mean home diastolic blood pressure (DBP) below 105 mmHg.
- Participants who were either untreated or receiving antihypertensive medication with inadequately controlled blood pressure. For participants receiving antihypertensive medication, drug classes and doses had to remain stable for at least 4 weeks before enrollment, with no planned active adjustment during the study.
- Completion of at least 2 weeks of twice-daily home blood pressure monitoring during screening, with the mean home SBP remaining within 135-179 mmHg before randomization.
- Ability and willingness to perform twice-daily home blood pressure monitoring and complete the 12-month intervention and follow-up.
- Provision of written informed consent.
Exclusion Criteria:
- Secondary hypertension of any cause or incomplete screening for secondary causes of hypertension.
- Cardiovascular or cerebrovascular events within 6 months before enrollment.
- Clinically significant arrhythmias, including atrial fibrillation or frequent ventricular premature beats, that could interfere with automated blood pressure measurement.
- Peripheral vascular disease, severe upper-limb vascular insufficiency, or conditions precluding safe cuff inflation, including an arteriovenous fistula in the measurement arm, lymphedema, skin lesions, or upper-limb surgery within the preceding 3 months.
- Orthostatic hypotension, defined as a systolic blood pressure decrease of at least 20 mmHg on standing or symptomatic orthostatic hypotension.
- Inter-arm systolic blood pressure difference greater than 15 mmHg.
- Severe target-organ damage, including estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m², left ventricular ejection fraction (LVEF) below 40%, or New York Heart Association (NYHA) functional class III-IV.
- Poorly controlled diabetes mellitus (HbA1c ≥9.0%) or established diabetic autonomic neuropathy.
- Pregnancy, planned pregnancy, or lactation.
- Participation in another interventional clinical trial within 30 days before enrollment.
- Inability to comply with the study protocol because of cognitive impairment, severe psychiatric disorders, or logistical difficulties with follow-up.
- Confirmed mean screening home DBP ≥105 mmHg on repeat measurement.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:階乗代入
- マスキング:4倍
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:CRIC+MFT
CRIC :Twice daily for 12 months using an automated cuff device. Each 30-minute session consisted of 3 cycles of 6 min inflation (pressure individualized: resting SBP-based increments of +40/+30/+20 mmHg depending on baseline SBP level) followed by 4 min deflation (0 mmHg). MFT:Twice daily guided audio sessions (synchronized with CRIC timing) emphasizing focused attention on breath and bodily sensations to foster mindful awareness. |
Remote Ischemic Conditioning (CRIC): Twice daily for 12 months using an automated cuff device. Each 30-minute session consisted of 3 cycles of 6 min inflation (pressure individualized: resting SBP-based increments of +40/+30/+20 mmHg depending on baseline SBP level) followed by 4 min deflation (0 mmHg). Mindfulness-based intervention (MFT) consisted of standardized audio-guided mindfulness practice focusing on breath awareness, bodily sensations, and nonjudgmental present-moment awareness. Each session lasted approximately 30 minutes and was delivered twice daily for 12 months, synchronized with the CRIC or sham CRIC procedure. |
|
実験的:sham CRIC+MFT
Sham CRIC: Identical schedule and device; each cycle used fixed 5 min inflation at 60 mmHg (non-ischemic) followed by 5 min deflation. MFT: Twice daily guided audio sessions (synchronized with CRIC timing) emphasizing focused attention on breath and bodily sensations to foster mindful awareness. |
Mindfulness-based intervention (MFT) consisted of standardized audio-guided mindfulness practice focusing on breath awareness, bodily sensations, and nonjudgmental present-moment awareness. Each session lasted approximately 30 minutes and was delivered twice daily for 12 months, synchronized with the CRIC or sham CRIC procedure. Mindfulness-based intervention (MFT) consisted of standardized audio-guided mindfulness practice focusing on breath awareness, bodily sensations, and nonjudgmental present-moment awareness. Each session lasted approximately 30 minutes and was delivered twice daily for 12 months, synchronized with the CRIC or sham CRIC procedure. |
|
実験的:CRIC+sham MFT
CRIC :Twice daily for 12 months using an automated cuff device. Each 30-minute session consisted of 3 cycles of 6 min inflation (pressure individualized: resting SBP-based increments of +40/+30/+20 mmHg depending on baseline SBP level) followed by 4 min deflation (0 mmHg). Sham MFT: Twice daily equivalent-duration audio of looped neutral nature sounds (ocean waves, flowing water, birdsong) without mindfulness instructions. |
Remote Ischemic Conditioning (CRIC): Twice daily for 12 months using an automated cuff device. Each 30-minute session consisted of 3 cycles of 6 min inflation (pressure individualized: resting SBP-based increments of +40/+30/+20 mmHg depending on baseline SBP level) followed by 4 min deflation (0 mmHg). The control audio consisted of standardized recordings of natural sounds, including ocean waves, flowing water, and birdsong, without mindfulness instructions, breathing exercises, or hypertension-related health education. Each audio session lasted approximately 30 minutes and was delivered twice daily for 12 months, synchronized with the CRIC or sham CRIC procedure. |
|
プラセボコンパレーター:Sham CRIC+Sham MFT
Sham CRIC: Identical schedule and device; each cycle used fixed 5 min inflation at 60 mmHg (non-ischemic) followed by 5 min deflation. Sham MFT: Twice daily equivalent-duration audio of looped neutral nature sounds (ocean waves, flowing water, birdsong) without mindfulness instructions. |
Mindfulness-based intervention (MFT) consisted of standardized audio-guided mindfulness practice focusing on breath awareness, bodily sensations, and nonjudgmental present-moment awareness. Each session lasted approximately 30 minutes and was delivered twice daily for 12 months, synchronized with the CRIC or sham CRIC procedure. The control audio consisted of standardized recordings of natural sounds, including ocean waves, flowing water, and birdsong, without mindfulness instructions, breathing exercises, or hypertension-related health education. Each audio session lasted approximately 30 minutes and was delivered twice daily for 12 months, synchronized with the CRIC or sham CRIC procedure. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change From Baseline in Home Systolic Blood Pressure at 12 Months
時間枠:Baseline (screening days -7 to -1) and Month 12 (days 335-364 after randomization)
|
Change in mean pre-intervention home systolic blood pressure (SBP) from screening baseline to the 12-month endpoint window. Home blood pressure was measured twice daily using an automated device. Three measurements were obtained before each intervention session; the first reading was excluded, and the mean of the remaining two readings was used. The 12-month endpoint was calculated as the mean of valid pre-intervention SBP measurements during days 335-364 after randomization. Participants with at least 20 valid measurement sessions during this window were included in the primary endpoint analysis. The outcome was expressed in mmHg. |
Baseline (screening days -7 to -1) and Month 12 (days 335-364 after randomization)
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change From Baseline in Home Diastolic Blood Pressure at 12 Months
時間枠:Baseline (screening days -7 to -1) and Month 12 (days 335-364)
|
Change in mean pre-intervention home diastolic blood pressure (DBP) from screening baseline to the 12-month endpoint window. Home blood pressure was measured twice daily using an automated device. Three measurements were obtained before each intervention session; the first reading was discarded, and the mean of the remaining two readings was used. The 12-month endpoint was calculated as the mean of valid pre-intervention DBP measurements during days 335-364 after randomization. Changes were expressed in mmHg. |
Baseline (screening days -7 to -1) and Month 12 (days 335-364)
|
|
Change From Baseline in Home Systolic Blood Pressure at Months 1, 3, 6, and 9
時間枠:Baseline and Days 30, 90, 180, and 270 after randomization
|
Changes in mean pre-intervention home systolic blood pressure (SBP) from screening baseline at multiple follow-up time points. Home SBP was measured twice daily using an automated device, with the mean of the second and third pre-intervention readings used for each session. Window-mean SBP values were calculated around days 30, 90, 180, and 270 after randomization to characterize the longitudinal blood pressure response to the assigned interventions. Changes were expressed in mmHg. |
Baseline and Days 30, 90, 180, and 270 after randomization
|
|
Proportion of Participants Achieving a Systolic Blood Pressure Reduction of at Least 5 mmHg
時間枠:Baseline and Month 12 (days 335-364)
|
Proportion of participants achieving a reduction of at least 5 mmHg in mean pre-intervention home systolic blood pressure from screening baseline to the 12-month endpoint window (days 335-364 after randomization). The response rate was calculated as the number of participants meeting this threshold divided by the number of participants with evaluable endpoint data, expressed as a percentage. |
Baseline and Month 12 (days 335-364)
|
|
Proportion of Participants Achieving Home Blood Pressure Control Below 135/85 mmHg
時間枠:Month 12 (days 335-364)
|
Proportion of participants achieving home blood pressure control, defined as a mean pre-intervention home systolic blood pressure below 135 mmHg and a mean pre-intervention home diastolic blood pressure below 85 mmHg during the 12-month endpoint window (days 335-364 after randomization). Blood pressure control rates were expressed as percentages among participants with evaluable endpoint data. |
Month 12 (days 335-364)
|
|
Proportion of Participants Achieving Home Blood Pressure Control Below 140/90 mmHg
時間枠:Month 12 (days 335-364)
|
Proportion of participants achieving home blood pressure control using a less stringent threshold, defined as a mean pre-intervention home systolic blood pressure below 140 mmHg and a mean pre-intervention home diastolic blood pressure below 90 mmHg during the 12-month endpoint window (days 335-364 after randomization). Blood pressure control rates were expressed as percentages among participants with evaluable endpoint data. |
Month 12 (days 335-364)
|
|
Within-Session Change in Home Systolic Blood Pressure
時間枠:Throughout the 12-month intervention period
|
The immediate blood pressure response was assessed as the difference between post-intervention and pre-intervention home systolic blood pressure within each treatment session. Three consecutive blood pressure measurements were obtained before and after each session, with the first reading excluded and the mean of the remaining two readings used for each time point. The participant-level mean of post-intervention minus pre-intervention SBP differences was calculated across available sessions. Between-group comparisons relative to the double-sham control group were used to estimate the net immediate intervention effect, expressed in mmHg. |
Throughout the 12-month intervention period
|
協力者と研究者
捜査官
捜査官
- スタディチェア:Muwei Li, MD、Chinese Academy of Medical Sciences, Fuwai Hospital
出版物と役立つリンク
一般刊行物
- Jones H, Hopkins N, Bailey TG, Green DJ, Cable NT, Thijssen DH. Seven-day remote ischemic preconditioning improves local and systemic endothelial function and microcirculation in healthy humans. Am J Hypertens. 2014 Jul;27(7):918-25. doi: 10.1093/ajh/hpu004. Epub 2014 Mar 13.
- Moro L, Pedone C, Mondi A, Nunziata E, Antonelli Incalzi R. Effect of local and remote ischemic preconditioning on endothelial function in young people and healthy or hypertensive elderly people. Atherosclerosis. 2011 Dec;219(2):750-2. doi: 10.1016/j.atherosclerosis.2011.08.046. Epub 2011 Sep 7.
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- HenanICE202103
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD can be obtained from the researcher upon reasonable request
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。